Commit To Buy Revance Therapeutics At $2.50, Earn 20.9% Annualized Using Options
April 12, 2024 at 11:38 AM EDT
Investors eyeing a purchase of Revance Therapeutics Inc (RVNC) stock, but tentative about paying the going market price of $4.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $2.50 strike, which has a bid at the time of this writing of 40 cents..